Milestone cancer vaccine success leaves hard questions unanswered
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Messenger RNA vaccine from Merck and Moderna slashes risk of melanoma’s return, but why remains unclear
Appeared: Saturday, October 31. Science. Peer-reviewed journal.